|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
Statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar
|
|
2
|
Leong SP, Cady B, Jablons DM, et al:
Clinical patterns of metastasis. Cancer Metastasis Rev. 25:221–232.
2006. View Article : Google Scholar
|
|
3
|
Stevanovic A, Lee P and Wilcken N:
Metastatic breast cancer. Aust Fam Physician. 35:309–312. 2006.
|
|
4
|
Liu S, Goldstein RH, Scepansky EM, et al:
Inhibition of rho-associated kinase signaling prevents breast
cancer metastasis to human bone. Cancer Res. 69:8742–8751. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Newman DJ: Natural products as leads to
potential drugs: an old process or the new hope for drug discovery?
J Med Chem. 51:2589–2599. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hristova K, Lam M, Feild T, et al:
Transmitting tissue ECM distribution and composition, and pollen
germinability in Sarcandra glabra and Chloranthus
japonicus (Chloranthaceae). Ann Bot. 96:779–791. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Editorial Committee of the Administration
Bureau of Traditional Chinese Medicine: genus
Chloranthaceae. Chinese Materia Medica (zhonghua
Bencao). Shanghai Science & Technology Press; Shanghai: pp.
2051–2061. 1998
|
|
8
|
Pan C, Xu H, Peng H, et al: Resource
investigation and exploitable foreground of Sarcandra
glabra. Zhong Yao Cai. 27:556–557. 2004.PubMed/NCBI
|
|
9
|
National Committee of Pharmacopoeia.
Pharmacopoeia of People’s Republic of China. 2010 ed. China Medical
Science Press; Beijing: pp. 8422010
|
|
10
|
Wang QH, Kuang HX, Yang BY, et al:
Sesquiterpenes from Chloranthus japonicus. J Nat Prod.
74:16–20. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang M, Wang JS, Wang PR, et al:
Sesquiterpenes from the aerial part of Chloranthus japonicus
and their cytotoxicities. Fitoterapia. 83:1604–1609. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kwon OE, Lee HS, Lee SW, et al: Dimeric
sesquiterpenoids isolated from Chloranthus japonicus
inhibited the expression of cell adhesion molecules. J
Ethnoparmacol. 104:270–277. 2006.PubMed/NCBI
|
|
13
|
Fu J, Ding Y, Huang D, et al: The retinoid
X receptor-selective ligand, LGD1069, inhibits tumor-induced
angiogenesis via suppression of VEGF in human non-small cell lung
cancer. Cancer Lett. 248:153–163. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chambers AF and Matrisian LM: Changing
views of the role of matrix metalloproteinases in metastasis. J
Natl Cancer Inst. 89:1260–1270. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Inman CK and Shore P: The osteoblast
transcription factor Runx2 is expressed in mammary epithelial cells
and mediates osteopontin expression. J Biol Chem. 278:48684–48689.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Roy R, Yang J and Moses MA: Matrix
metalloproteinases as novel biomarkers and potential therapeutic
targets in human cancer. J Clin Oncol. 27:5287–5297. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Duffy MJ, Maguire TM, Hill A, et al:
Metalloproteinases: role in breast carcinogenesis, invasion and
metastasis. Breast Cancer Res. 2:252–257. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Radisky ES and Radisky DC: Matrix
metalloproteinase-induced epithelial-mesenchymal transition in
breast cancer. J Mammary Gland Biol Neoplasia. 15:201–212. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lian JB, Stein JL, Stein GS, et al:
Runx2/Cbfa1 functions: diverse regulation of gene transcription by
chromatin remodeling and co-regulatory protein interactions.
Connect Tissue Res. 44:141–148. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Karsenty G: Role of Cbfa1 in osteoblast
differentiation and function. Semin Cell Dev Biol. 11:343–346.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Komori T: Runx2, a multifunctional
transcription factor in skeletal development. J Cell Biochem.
87:1–8. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Stein GS, Lian JB, van Wijnen AJ, et al:
Runx2 control of organization, assembly and activity of the
regulatory machinery for skeletal gene expression. Oncogene.
23:4315–4329. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Inman CK, Li N and Shore P: Oct-1
counteracts autoinhibition of Runx2 DNA binding to form a novel
Runx2/Oct-1 complex on the promoter of the mammary gland-specific
gene beta-casein. Mol Cell Biol. 25:3182–3193. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Barnes GL, Javed A, Waller SM, et al:
Osteoblast-related transcription factors Runx2 (Cbfa1/AML3) and
MSX2 mediate the expression of bone sialoprotein in human
metastatic breast cancer cells. Cancer Res. 63:2631–2637. 2003.
|
|
25
|
Shore P: A role for Runx2 in normal
mammary gland and breast cancer bone metastasis. J Cell Biochem.
96:484–489. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ganss B, Kim RH and Sodek J: Bone
sialoprotein. Crit Rev Oral Biol Med. 10:79–98. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bellahcène A and Castronovo V: Expression
of bone matrix proteins in human breast cancer: potential roles in
microcalcification formation and in the genesis of bone metastases.
Bull Cancer. 84:17–24. 1997.PubMed/NCBI
|
|
28
|
Sun L, Vitolo M and Passaniti A:
Runt-related gene 2 in endothelial cells: inducible expression and
specific regulation of cell migration and invasion. Cancer Res.
61:4994–5001. 2001.PubMed/NCBI
|
|
29
|
Chimge NO, Baniwal SK, Little GH, et al:
Regulation of breast cancer metastasis by Runx2 and estrogen
signaling: the role of SNAI2. Breast Cancer Res. 13:R1272011.
View Article : Google Scholar
|
|
30
|
Jiménez MJ, Balbín M, López JM, et al:
Collagenase 3 is a target of Cbfa1, a transcription factor of the
runt gene family involved in bone formation. Mol Cell Biol.
19:4431–4442. 1999.PubMed/NCBI
|
|
31
|
Selvamurugan N and Partridge NC:
Constitutive expression and regulation of collagenase-3 in human
breast cancer cells. Mol Cell Biol Res Commun. 3:218–223. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Selvamurugan N, Kwok S and Partridge NC:
Smad3 interacts with JunB and Cbfa1/Runx2 for transforming growth
factor-beta1-stimulated collagenase-3 expression in human breast
cancer cells. J Biol Chem. 279:27764–27773. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pratap J, Javed A, Languino LR, et al: The
Runx2 osteogenic transcription factor regulates matrix
metalloproteinase 9 in bone metastatic cancer cells and controls
cell invasion. Mol Cell Biol. 25:8581–8591. 2005. View Article : Google Scholar
|
